Abstract |
Tariquidar was developed as a specific inhibitor of the efflux transporter ABCB1. Recent positron emission tomographic brain imaging studies using [(11)C] tariquidar to measure ABCB1 (P-gp, P-glycoprotein) density in mice indicate that the inhibitor may not be as specific as previously thought. We examined its selectivity as an inhibitor and a substrate for the human transporters P-gp, breast cancer resistance protein (BCRP, ABCG2), and multidrug resistance protein 1 ( MRP1, ABCC1). Our results show that at low concentrations, tariquidar acts selectively as an inhibitor of P-gp and also as a substrate of BCRP. At much higher concentrations (≥100 nM), tariquidar acts as an inhibitor of both P-gp and BCRP. Thus, the in vivo specificity of tariquidar depends on concentration and the relative density and capacity of P-gp vs BCRP.
|
Authors | Pavitra Kannan, Sanjay Telu, Suneet Shukla, Suresh V Ambudkar, Victor W Pike, Christer Halldin, Michael M Gottesman, Robert B Innis, Matthew D Hall |
Journal | ACS chemical neuroscience
(ACS Chem Neurosci)
Vol. 2
Issue 2
Pg. 82-9
(Feb 16 2011)
ISSN: 1948-7193 [Electronic] United States |
PMID | 22778859
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- ABCB1 protein, human
- ABCG2 protein, human
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
- Neoplasm Proteins
- Quinolines
- tariquidar
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(antagonists & inhibitors, metabolism)
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
(antagonists & inhibitors, metabolism)
- Breast Neoplasms
(drug therapy, metabolism)
- Cell Line, Tumor
- Drug Resistance, Multiple
(drug effects, physiology)
- Female
- HEK293 Cells
- Humans
- Neoplasm Proteins
(antagonists & inhibitors, metabolism)
- Quinolines
(chemistry, metabolism, pharmacology)
- Substrate Specificity
(drug effects)
|